Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 24.60B | 24.00B | 22.85B | 21.80B | 20.79B |
Gross Profit | 6.72B | 6.59B | 5.99B | 5.57B | 5.26B |
EBITDA | 3.50B | 3.47B | 3.04B | 2.64B | 2.40B |
Net Income | 2.24B | 2.27B | 1.97B | 1.62B | 1.42B |
Balance Sheet | |||||
Total Assets | 25.16B | 23.89B | 21.72B | 19.96B | 18.43B |
Cash, Cash Equivalents and Short-Term Investments | 7.79B | 6.55B | 5.59B | 4.70B | 3.84B |
Total Debt | 1.52B | 1.87B | 1.97B | 2.14B | 2.15B |
Total Liabilities | 6.63B | 6.89B | 6.52B | 6.35B | 6.11B |
Stockholders Equity | 18.53B | 17.00B | 15.15B | 13.59B | 12.30B |
Cash Flow | |||||
Free Cash Flow | 2.28B | 2.06B | 1.75B | 1.66B | 1.68B |
Operating Cash Flow | 2.38B | 2.19B | 1.94B | 1.80B | 1.85B |
Investing Cash Flow | 43.88M | -673.38M | -379.00M | -134.80M | 48.60M |
Financing Cash Flow | -1.14B | -803.57M | -678.10M | -602.21M | -922.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥27.50B | 12.36 | 2.81% | 2.50% | -1.49% | ||
81 Outperform | ¥25.89B | 12.68 | 4.36% | 13.49% | 24.79% | ||
77 Outperform | ¥27.06B | 11.25 | 1.15% | 11.94% | 14.10% | ||
76 Outperform | ¥26.37B | 17.15 | 1.93% | 20.75% | 31.02% | ||
74 Outperform | ¥23.93B | 32.62 | 1.76% | 7.60% | -6.99% | ||
63 Neutral | $34.70B | 5.15 | -11.38% | 1.67% | 5.54% | -17.15% | |
56 Neutral | ¥29.28B | 52.75 | ― | -17.30% | ― |